Hester Biosciences Limited (BOM: 524669)

Market Cap	20.94B
Revenue (ttm)	3.06B
Net Income (ttm)	193.56M
Shares Out	8.51M
EPS (ttm)	22.91
PE Ratio	107.43
Forward PE	n/a
Dividend	6.00 (0.24%)
Ex-Dividend Date	Aug 22, 2024

Volume	92
Open	2,449.00
Previous Close	2,418.55
Day's Range	2,446.20 - 2,521.90
52-Week Range	1,292.90 - 3,375.45
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About Hester Biosciences

Hester Biosciences Limited manufactures and trades in veterinary vaccines and animal health products in India and internationally. It operates through Poultry Healthcare, Animal Healthcare, and Petcare segments. The company provides poultry vaccines for newcastle disease, infectious bronchitis, infectious bursal disease, fowl pox, marek’s disease, infectious coryza, fowl cholera, inclusion body hepatitis, fowl typhoid, and avian encephalomyelitis. It also offers livestock vaccines for goat pox, peste des petits ruminants, brucella abortus, cont...

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 1987
• Employees: 642
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 524669

Financial Performance

In 2023, Hester Biosciences's revenue was 3.11 billion, an increase of 11.86% compared to the previous year's 2.78 billion. Earnings were 188.89 million, a decrease of -29.06%.